Following Swecare’s series of webinars together with Medtech4Health, and leveraging on the recent State Visit to Sweden by Their Majesties the King and Queen of the Netherlands, we are now taking the next step by arranging a fact-finding mission with focus on The Hague, Leiden and Amsterdam.
Sweden and the Netherlands rank equally in terms of innovation, digitalization, and competitiveness – but with fundamentally different healthcare structures. Swedish life science companies looking to grow in the Netherlands face a privatized system with different stakeholders than in Sweden. But working together is part of the Dutch DNA, with a strong culture of collaboration supporting a thriving digital healthcare, oncology, and cardiovascular ecosystem.
During this delegation, we aim to focus on digital healthcare and oncology. Stakeholders we aim to include are:
- The Hague: Ministry of Health, Welfare and Sport; Health-Holland; Task Force Health Care; Nictiz
- Leiden: Leiden University Medical Center; NeLL Hub; Leiden BioScience Park; Zilveren Kruis
- Amsterdam: Netherlands Cancer Institute (NKI-AVL); Amsterdam University Medical Center; National GP Association
We look forward to welcoming you to the Netherlands
Swecare and Business Sweden
